Paper Details

  1. Home
  2. Paper Details

Efficacy and Side Effects of Combined Capecitabine Plus Intensity Modulated Radiotherapy as an Effective Adjuvant Therapy for Gastric Cancers.

Author: FuJie, LiHong-Ling, ShaoYu-Hui, SunYi, WangChun-Gang, WangChun-Yan, YangXiao-Jing, YangXin-Miao, ZhangLi-Hua, ZhangXiu-Long

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the clinical outcomes and toxicities associated with intensity modulated radiotherapy (IMRT) and capecitabine for gastric cancer. The combined treatment was well-tolerated and resulted in few side effects.
Paper Details　
Original Abstract of the Article :
This study aims to evaluate the clinical outcomes and the toxicities associated with intensity modulated radiotherapy (IMRT) administered in combination with capecitabine for gastric cancer. This study was conducted between July 2009 and October 2011, and included 31 patients (23 female and eight ma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019857/

データ提供：米国国立医学図書館（NLM）

Combined Capecitabine and Intensity Modulated Radiotherapy for Gastric Cancer

This study explores the efficacy and safety of combining capecitabine with intensity modulated radiotherapy (IMRT) as an adjuvant therapy for gastric cancer. The researchers embark on a journey through the desert of cancer treatment, seeking to understand the potential benefits of this combined approach. They examine the clinical outcomes and toxicities associated with this regimen, aiming to optimize treatment strategies for gastric cancer patients.

A Promising Adjuvant Therapy for Gastric Cancer

The study found that combined IMRT and capecitabine was well-tolerated and associated with favorable clinical outcomes in patients with gastric cancer. It's like discovering a hidden oasis of effective treatment, offering a path to improved survival and quality of life. This research suggests that this combined therapy can be a valuable tool for managing gastric cancer, offering a potential improvement over traditional treatment approaches.

Improving Treatment Options for Gastric Cancer

The study underscores the importance of exploring new and effective treatment strategies for gastric cancer. It highlights the potential benefits of integrating IMRT with capecitabine as a promising adjuvant therapy, offering a potential improvement over traditional treatment approaches. It's like expanding the map of gastric cancer treatment, seeking to find the most effective routes to recovery.

Dr. Camel's Conclusion

This research offers a glimmer of hope in the desert of gastric cancer treatment. It suggests that combining IMRT with capecitabine can be a valuable tool for managing this challenging disease, potentially improving survival and quality of life for patients. It's like discovering a new oasis of effective treatment, offering a path to improved outcomes and greater hope for patients with gastric cancer.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-04-13
Further Info :

Pubmed ID

33841549

DOI: Digital Object Identifier

PMC8019857

Related Literature

Article Analysis
・Effects of capecitabine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.